 |
|
Alireza Abazari, PhD
University of Alberta, 2010
My current research interests include studying long-term preservation of cells and tissues by cryo and anhydrobiotic methods. I investigate the underlying damage mechanisms to trehalose-loaded cells during dehydration, desiccation and rehydration |
 |
|
Shyam Sundhar Bale, PhD
Rensselaer Polytechnic Institute, 2010
My primary research is to develop a microfluidic platform for real-time detection of cellular secretions. This technology will be combined with the living cell array so that we can simultaneously monitor gene expression and protein secretion. |
 |
|
Bote G. Bruinsma, MSc (MD/PhD student)
University of Amsterdam, 2012
Using an ex vivo machine perfusion system, I'm attempting to demonstrate that donor livers for transplantation can be metabolically sustained outside the body at higher temperatures and even improved in viability. This way we hope to improve the quality marginal donor livers, decrease the complications of transplantation, and increase the amount of livers available for transplant. |
 |
|
Abhinav Bhushan, PhD
Louisiana State University, 2007
My main research interest is to develop in vitro microfluidic models of human diseases, including dermal contact hypersensitivity. Another is to develop strategies for sensitive detection of biomolecules as early indicators of diseases for more effective diagnosis. |
 |
|
Hansang Cho, PhD
UC Berkeley, 2010
My research focuses on studying cellular interactions and migration using microfluidic platforms. Specifically, I am working on microglia-neuron interaction in the context of Alzheimer’s disease and monocyte-neutrophil interaction during inflammation. |
 |
|
Alex Golberg, PhD
Hebrew University of Jerusalem, 2011
I am developing wound healing therapies. My research goal is to identify processes that lead to scarless tissue regeneration and to apply multitarget therapies to prevent scarring. I use non-thermal irreversible electroporation injury model to understand and quantify skin regeneration with reduced hypertrophic scars. |
 |
|
Anh N. Hoang, PhD
My research goals are to develop a microfluidic platform for the concentration
of tuberculosis (TB)from sputum samples for point of care detection and to
amplify the capture efficiency of circulating tumor cells(CTC) using a dendrimer
approach. |
 |
|
Maria-Louisa Izamis, PhD
MIT, 2010
I am developing methodology to reengineer discarded donor organs into transplantable grafts. Our ex vivo liver perfusion system provides a window of opportunity in which to objectively assess and improve organ viability so that even marginal organ can be transplanted. |
 |
|
Jungwoo Lee, PhD
U Michigan, 2009
I am developing ex vivo human bone marrow and lymph node tissue model systems combining microfluidics and 3D cell culture matrices. I am also working on modulating body’s immune responses utilizing messenchyaml stem cells and engineered microparticles. |
 |
|
William McCarty, PhD
University of California – San Diego, 2012
My main interests are in how fluid and macromolecular transport processes direct cell metabolism. I study hepatic zonation, intercellular transport through gap junctions, and work with the Microphysiological Systems group developing a microfluidic liver to predict drug metabolism. |
 |
|
Suraj Patel, PhD
MIT, 2010
I am currently working on a project the aim of which is to develop hepatotoxicity treatments by using inhibition of gap junction communication as the vehicle. A portion of my effort is dedicated to high throughput screens of novel gap junction inhibitors from large chemical libraries. |
 |
|
Gautham Vivek Sridharan, PhD
Tufts University, 2013
My primary research thrust lies in bridging computational systems biology and experimental metabolomics to study the dynamics of metabolic systems. Specifically, I am working to characterize the dynamic behavior of human livers during ex vivo machine perfusion to optimize organ recovery and ultimately expand the pool of transplantable livers. |
 |
|
Keyue Shen, PhD
Columbia University, 2010
My current research is on developing engineered tumor models to study tumor-stroma interactions. I am interested in understanding the role of these interactions in tumor's resistance to various treatments, in order to eventually improve anti-cancer therapeutics. |
